TCL Archive NCI Implementing Changes In Organ Site Program, Directing Grant applications To NIH Study Sections October 15, 1982
TCL Archive ODAC Advice Poses Challenge to FDA: Would Iressa Approval Erode Standards? November 8, 2002
TCL Archive Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint November 25, 2011
TCL Archive Broder Appointment Official; Will Keep Retroviral Laboratory, Will Not Serve as NCI Clinical Director January 6, 1989
